Filing Flows › RXO (RXO) › Q2 2026 › vs Q1 2026
RXO (RXO) Q2 2026 vs Q1 2026 (quarter over quarter)
RXO's revenue rose $349M (+24%) from $1.4B in Q1 2026 to $1.8B in Q2 2026.
RXO, Q2 2026: revenue $1.8B (+25% year over year), operating margin 0.1%, net loss $9.0M, operating cash flow −$40.0M. The chart draws each line against Q1 2026, the increases inside each band.
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $1.8B | $1.4B | $349M | +24% |
| Net loss | $9.0M | $36.0M | −$27.0M | -75% |
| Costs & expenses | $1.8B | $1.5B | $309M | +21% |
| Operating costs | $1.8B | $1.5B | $320M | +22% |
| Interest & other, net | $9.0M | $21.0M | −$12.0M | -57% |
| Income tax | $1.0M | −$13.0M | $14.0M | — |
| Cost of revenue | $1.5B | $1.2B | $301M | +26% |
| SG&A | $211M | $197M | $14.0M | +7% |
| Other operating costs | $90.0M | $85.0M | $5.0M | +6% |
| Operating cash sources | $73.0M | $40.0M | $33.0M | +82% |
| Depreciation & amortization | $26.0M | $26.0M | $0 | 0% |
| Share-based compensation | $7.0M | $7.0M | $0 | 0% |
| Cash used in operations | $40.0M | $7.0M | $33.0M | +471% |
| Net loss absorbed | $9.0M | $36.0M | −$27.0M | -75% |
| Working capital & other | $64.0M | $4.0M | $60.0M | 16× |
Questions
How much did RXO's revenue grow quarter over quarter in Q2 2026?
RXO's revenue rose $349M (+24%) from $1.4B in Q1 2026 to $1.8B in Q2 2026.